Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

No reported Stock-Based Compensation figures are available to summarize.

Stock-Based Compensation history

Currency unavailable · from the cash flow

No Stock-Based Compensation data reported for this period type.

Stock-Based Compensation vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Stock-Based Compensation for LTGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PCRXPacira BioSciences, Inc.LTM Mar 2026$56.49M USD+7.4%+6.1%7.7%
COLLCollegium Pharmaceutical, Inc.LTM Mar 2026$41.26M USD+13.2%+22.4%5.2%
SCLXScilex Holding CompanyLTM Mar 2026$10.16M USD-34.5%+43.2%30.0%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —+7.4%+22.4%7.7%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.